1 month Fulcrum Therapeutics, Inc. (NASDAQ:FULC) Receives Consensus Rating of “Hold” from AnalystsMarketBeat
Shares of Fulcrum Therapeutics, Inc. (NASDAQ:FULC – Get Free Report) have received a consensus recommendation of “Hold” from the ten brokerages that are currently covering the stock, MarketBeat.com reports. One research analyst has rated the stock wi…
X